Has the Veterans Review and Appeal Board ever been given the following information and, if so, when and by whom: ( a ) the reason that the day mefloquine was administered is referred to as psycho Tuesday or Wednesday, et cetera, by soldiers deployed to Somalia; ( b ) the March 1991 CF protocol entitled “Mefloquine Availability”, concerning (i) potential central nervous system side effects, (ii) lingering concerns in the U.S. army over CNS side effects, (iii) inadequate data and (iv) lack of Canadian forces experience with the drug; ( c ) the problems resulting from mefloquine use in the relief mission to Somalia as reported in January 1993 CF medical report entitled “Medical Post-Op Report—Op Relief”; ( d ) the problems resulting from mefloquine use in the deployment to Somalia as reported in the April 1993 CF medical report from HMCS Preserver entitled “Post Deployment Report Op Deliverance 16 November 1992—7 April 1993”; ( e ) the problems resulting from mefloquine use in the deployment to Somalia as reported in the October 1993 CF medical report entitled “Medical Operations in Somalia, Surgical Section”; ( f ) the evidence and findings of the Somalia Inquiry in regard to the effects of mefloquine on soldiers deployed to Somalia; ( g ) that the mefloquine administered to soldiers in the Somalia deployment was an unlicensed drug obtained through a clinical study; ( h ) that the Canadian forces failed to systematically monitor either efficacy or adverse reactions as required by the Food and Drug Act for each solder who received mefloquine in the Somalia deployment; and ( i ) that the death in 1994 of a Canadian soldier deployed to Somalia and then to Rwanda was found both by the Canadian forces and the United Nations to have been mefloquine related?
In the House of Commons on June 8th, 1999. See this statement in context.